Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Molecular biology of primary pulmonary hypertension.

Mandegar M, Thistlethwaite PA, Yuan JX.

Cardiol Clin. 2004 Aug;22(3):417-29, vi. Review.

PMID:
15302361
2.

Novel insertional mutation in the bone morphogenetic protein receptor type II associated with sporadic primary pulmonary hypertension.

Sugiyama S, Hirota H, Yoshida M, Takemura Y, Nakaoka Y, Oshima Y, Terai K, Izumi M, Fujio Y, Hasegawa S, Mano T, Nakatsuchi Y, Hori M, Yamauchi-Takihara K, Kawase I.

Circ J. 2004 Jun;68(6):592-4.

3.

Genetics of primary pulmonary hypertension.

Thomas AQ, Gaddipati R, Newman JH, Loyd JE.

Clin Chest Med. 2001 Sep;22(3):477-91, ix. Review.

PMID:
11590842
4.
5.

Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation.

Abramowicz MJ, Van Haecke P, Demedts M, Delcroix M.

Eur Respir J. 2003 Sep;22(3):560-2. Review.

6.

Pathobiology of pulmonary arterial hypertension.

Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S.

Eur Respir J. 2002 Dec;20(6):1559-72. Review.

7.

Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension.

De Caestecker M, Meyrick B.

Respir Res. 2001;2(4):193-7. Epub 2001 Jun 11. Review.

8.

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW.

Circulation. 2002 Apr 9;105(14):1672-8.

9.

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC.

Am J Hum Genet. 2001 Jan;68(1):92-102. Epub 2000 Dec 12.

10.

Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.

Abdalla SA, Gallione CJ, Barst RJ, Horn EM, Knowles JA, Marchuk DA, Letarte M, Morse JH.

Eur Respir J. 2004 Mar;23(3):373-7.

11.

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.

Morse JH.

Chest. 2002 Mar;121(3 Suppl):50S-53S. No abstract available.

PMID:
11893684
12.

Genetics and pulmonary hypertension.

Loyd JE.

Chest. 2002 Dec;122(6 Suppl):284S-286S. Review.

PMID:
12475800
13.

Insights into the genetic and molecular basis of primary pulmonary hypertension.

Trembath RC, Harrison R.

Pediatr Res. 2003 Jun;53(6):883-8. Epub 2003 Mar 5.

PMID:
12621102
14.

[Genetics of primary pulmonary hypertension].

Korniszewski L, Bartczak R.

Pol Arch Med Wewn. 2004 Apr;111(4):501-9. Review. Polish. No abstract available.

PMID:
15517766
15.

Specific bone morphogenic protein receptor II mutations found in primary pulmonary hypertension cause different biochemical phenotypes in vitro.

Thomas AQ, Carneal J, Markin C, Lane KB, Phillips JA 3rd, Loyd JE, Gaddipati R.

Chest. 2002 Mar;121(3 Suppl):83S. No abstract available.

PMID:
11893707
16.

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

International PPH Consortium, Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC.

Nat Genet. 2000 Sep;26(1):81-4.

PMID:
10973254
17.

Genetic aspects of pulmonary arterial hypertension.

Morse JH, Deng Z, Knowles JA.

Ann Med. 2001 Dec;33(9):596-603. Review.

PMID:
11817654
18.
19.
20.

BMPR2 mutations found in Japanese patients with familial and sporadic primary pulmonary hypertension.

Morisaki H, Nakanishi N, Kyotani S, Takashima A, Tomoike H, Morisaki T.

Hum Mutat. 2004 Jun;23(6):632. Erratum in: Hum Mutat. 2004 Sep;24(3):275.

PMID:
15146475

Supplemental Content

Support Center